Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Healthcare Biotechnology
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate... see more

Current News (NYSE:BIO)

Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

Business Wire February 12, 2026

Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

Business Wire January 29, 2026

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference

Business Wire January 6, 2026

Bio-Rad Reports Third-Quarter 2025 Financial Results

Business Wire October 29, 2025

Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025

Business Wire October 16, 2025

Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away

Business Wire September 29, 2025

Bio-Rad's Management to Participate in Upcoming Investor Conferences

Business Wire August 25, 2025

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

Business Wire August 1, 2025

Bio-Rad Reports Second-Quarter 2025 Financial Results

Business Wire July 31, 2025
View More News ››

Opinion & Analysis (NYSE:BIO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:BIO)

Cell Analysis Market Analysis 2022: Industry Report

According to IMARC Group’s latest report, titled "Cell Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity...
edwardebreen15 - August 19, 2022

SZLS

https://www.stagezerolifesciences.com/prostate-health-index.html
FacBine - September 25, 2019

ODOR CONTROL - FOR MJ

https://www.ftmig.com/resources/matica-and-yunify-develop-first-new-consumer-product/
crude - November 7, 2018
View more Bullboard ››

Diagnostear Technologies Inc

Diagnostear Technologies Inc

DiagnosTear Technologies Inc., an ophthalmic company, engages in developing and commercializing disruptive diagnostic ...
View More »

Podcasts